Treatment of central giant cell granuloma with denosumab: A case report of a complicated treatment course

Pediatr Blood Cancer. 2022 Jun;69(6):e29436. doi: 10.1002/pbc.29436. Epub 2021 Nov 12.

Authors

Katrien Brijs¹, Koenraad Veys², Serge Schepers³, Heidi Segers⁴, Constantinus Politis¹

Affiliations

¹ OMFS IMPATH Research Group, Department of Imaging & Pathology, Faculty of Medicine, KU Leuven & Oral and Maxillofacial Surgery, University Hospitals Leuven, Leuven, Belgium.
² Department of Pediatric Nephrology, University Hospitals Leuven, Leuven, Belgium.
³ Department of Oral and Maxillofacial Surgery, Ziekenhuis Oost-Limburg Genk, Genk, Belgium.
⁴ Department of Pediatric Oncology, University Hospitals Leuven, Leuven, Belgium.

PMID: 34767309
DOI: 10.1002/pbc.29436

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Bone Density Conservation Agents* / therapeutic use
Bone Neoplasms* / drug therapy
Denosumab / therapeutic use
Giant Cell Tumor of Bone* / drug therapy
Granuloma, Giant Cell* / drug therapy
Humans

Substances

Bone Density Conservation Agents
Denosumab